| [Download PDF]
|Year : 2008 | Volume
| Issue : 4 | Page : 170--174
The effects of topical (gel) astemizole and terfenadine on wound healing
D Srikanth, Rekha R Shenoy, C Mallikarjuna Rao
Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal, Karnataka, India
C Mallikarjuna Rao
Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal, Karnataka
Objective: To develop topical gel preparations of astemizole and terfenadine and to investigate the actions of the gels on the healing of incision and excision wounds in male albino rats.
Materials and Methods: Gels containing 1% astemizole, with varying concentrations of carbopol 934 (polymer), were prepared. Similarly, 1% terfenadine gels were made. The formulations were evaluated for release rate and stability. Incision and excision wounds were inflicted on male albino rats under ketamine anesthesia, taking aseptic precautions. The animals were divided into two groups. They were given a topical application of either astemizole or terfenadine gel, at a dose of 100 mg per wound, once daily, for 10 days in the case of incision wounds and till the time of complete closure in the case of excision wounds. On the 11 th day, breaking strength of the incision wound was measured. In the excision wound model, wound closure rate, epithelization time, scar features and hydroxyproline content of scar tissue were studied from the day of wounding till the day of the scab falling off, with no residual raw area.
Results: Gels prepared using 0.8% carbopol 934 and 1% of drug in gel base were found to be stable. The gels of astemizole and terfenadine significantly (P < 0.05) promoted the phases of healing such as collagenation (in incision wounds), wound contraction and epithelization (in excision wounds).
Conclusion: The gels of astemizole and terfenadine might play an important role in wound management program.
|How to cite this article:|
Srikanth D, Shenoy RR, Rao C M. The effects of topical (gel) astemizole and terfenadine on wound healing.Indian J Pharmacol 2008;40:170-174
|How to cite this URL:|
Srikanth D, Shenoy RR, Rao C M. The effects of topical (gel) astemizole and terfenadine on wound healing. Indian J Pharmacol [serial online] 2008 [cited 2023 May 30 ];40:170-174
Available from: https://www.ijp-online.com/text.asp?2008/40/4/170/43164
Wound healing is a complex and complicated process. It runs through a number of phases, which either run concurrently or are intimately interlinked through some chemical, biochemical and cellular pathways. A treatment could influence the healing of wound by intervening in any one or many phases of healing. No treatment, either systemic or local, could be considered inert on healing process,  unless it is proved experimentally.
Histamine is one of the mediators of acute inflammation. The exact contribution of histamine to repair the process of a wound is difficult to ascertain. However, histamine causes itching in the healing wound and the healed wound (scar). If itching is not contained in the healing wound, it may hamper the healing process or may cause damage to the scar. Doxepin, an antidepressant having anti-histaminic activity, upon topical use, has been shown to reduce the itching in burn wound and scars. However, its influence on healing has not been studied. Thus, it is interesting to study the influence of topical antihistaminics on healing.
Astemizole and terfenadine were among the first nonsedating antihistaminic drugs to be introduced for therapeutic use. Subsequently their cardiac toxicity, e.g. ventricular fibrillation and torsades de pointes was discovered when they were given systemically, in high doses and in combination with CYP3A4 inhibitors. The occurrence of many such cases of cardiac toxicity led to a drastic reduction in their use. No attempt has so far been made to discover their topical utility, particularly in wound healing. Thus, the present work was aimed at studying a new use of these drugs in a new dosage form.
The study was, therefore, conducted on the healing of incision and excision wounds, using the gel preparations of terfenadine and astemizole.
Materials and Methods
Preparation of gels 
Formulation: Gels containing 1% of astemizole/terfenadine, with varying concentrations of carbopol (0.6%, 0.8% and 1.0%) were prepared. The gels were tested for stability, content uniformity and in vitro release through excised mouse skin. Gels containing 0.8% carbopol 934 and 1% of drug in gel base were finally selected for wound healing studies, as these were found to be more stable and had good release rates than the others. The compositions of these gels are as follows:
Carbopol 934 - 80 mg
Propylene glycol - 1 ml
Ethanol - 2 ml
Water - 5.2 ml
DMSO - 1.5 ml
Triethanolamine - q.s.
Astemizole - 100 mg
Carbopol 934 - 80 mg
Propylene glycol - 1 ml
Ethanol - 2 ml
Water - 5.2 ml
DMSO - 1.5ml
Triethanolamine - q.s.
Terfenadine - 100 mg
The gels were kept in collapsible tubes and were placed in the stability chamber, which was maintained at 40ºC and 75% relative humidity for 90 days. The gels were then observed for any change in the consistency and color. Besides, the drug content uniformity was evaluated as described below.
Five hundred milligram of the gel was taken and dissolved in a small amount of buffer pH 7.4. The volume was made up with buffer. The absorbance was measured at 284 and 258 nm respectively, for astemizole and terfenadine.
In vitro release studies through excised rat skin 
The rat skin soaked in buffer for 6-8 h was clamped carefully to one end of the dialysis cell (donor compartment). Fifty milliliter phosphate buffer saline (PBS) containing 20% ethanol was taken in a beaker (receptor compartment). Gel, of 1 g quantity, was spread uniformly on the membrane. The donor compartment was kept in contact with the receptor compartment. The temperature was maintained at 37 ± 0.1°C. At predetermined time intervals, 1 ml of the solution was pipetted out from the receptor compartment and immediately replaced with 1 ml of fresh PBS. The drug concentration of the acceptor fractions was determined against appropriate blank.
Wound healing studies
Healthy inbred male albino rats of Wistar strain, weighing 180-200 g were selected. They were individually housed and maintained on normal food and water ad libitum , under standard living conditions of room temperature 25 o C and day and night reverse cycle. The surgical interventions, under ketamine anesthesia (10 mg/kg), were carried out on the shaven back of the animals. Under each wound model of study, the wound bearing animals were divided into four groups, each group containing eight animals (n = 8). The first group of animals was left untreated and served as control. The second, third and fourth groups of animals received the topical applications, viz. gel base (base control), astemizole gel and terfenadine gel respectively, at approximately 100 mg per wound, once daily for 10 days in the case of incision wounds and a maximum of 20 days in the case of animals with excision wounds, starting from the day of surgery.
Incision wound: Two para-vertebral straight incisions of 6 cm each were made through the entire thickness of skin on either side, at least one cm lateral to the vertebral column, as per the methods described by Ehrlich and Hunt.  The sutures were removed on the 7 th day of wounding. The wound breaking strengths were measured on the 10 th day of wounding by continuous, constant water flow technique, as described by Lee. 
Excision wound: Excision wounds were made as described by Morton and Malone,  by excising the full thickness circular skin (approximately 500 mm 2 ) from the nape of neck, under ketamine anesthesia. Wound contraction was assessed by tracing the wound area on polythene paper first and subsequently on a mm sq paper, every alternate day. The wound closure rate was expressed as percentage of the original wound size of 500 mm 2 on selected days.
On day 15, an animal from each of the treated groups was sacrificed and the wound was excised and fixed in neutral buffered 10% formalin. Later, paraffin sections of 5 micron were made and stained with H & E stain for histopathological evaluation.
The number of days required for the scab to fall off without leaving a raw wound behind was considered the period of epithelization.
Healed scar on the day of epithelization was excised and used for determination of hydroxyproline content. 
The experimental protocols were approved by the Institutional Animal Ethics Committee of MAHE, Manipal.
Results were analyzed using the one-way anova, followed by post hoc test, viz. Scheffe's test using the Windows based SPSS computer package.
Both the gel formulations of terfenadine and astemizole showed 99% drug content uniformity in their formulations [Table 1].
Gels of terfenadine and astemizole, containing 0.8% carbopol 934 and 1% of drug were found to be stable in the accelerated stability studies, as there was no change in the color and consistency. Besides, air bubbles and crystals did not appear during the studies.
In vitro release studies of astemizole and terfenadine through rat skin
The release of the drugs from the formulations was progressive and steady. At the seventh hour, the rates of release of astemizole and terfenadine from their gel formulations were 71.30% and 67.85% respectively [Table 2].
Wound Healing Studies
The mean strength of the healed wound scar in control group of animals was 266 g. While the base of the gels did not influence the strength of the scar, both astemizole and terfenadine gels significantly increased ( P Excision wound
In control group, wound contracted to the extent of 3.7, 37, 74 and 91% by days 2, 6, 10 and 14. The gel base treatment, however, enhanced the wound closer rate on day 6 and 10. Wounds of the animals, which received astemizole, showed a similar rate of contraction as that of gel base on day 6 and day 10. However, these wounds contracted significantly faster than the gel base treated wounds on day 14. On the other hand, terfenadine gel showed significantly ( P P P Histopathological evaluation
The wound sections from the animal in control group had a few notable histological observations such as more organized collagen, less number of inflammatory cells and blood vessels - markers of near complete healing. Besides, the growth of epithelial tongues was prominent in these sections [Figure 1]. The features of the sections of the gel base were almost similar to those of control [Figure 2]. On the other hand, the features of the sections of astemizole and terfenadine treated wounds were that of advanced healing, as compared to that of the control or gel base. In these sections, there was complete restoration of epithelial growth, similar to that seen in normal skin. Inflammatory cells appear almost negligible in the dermis [Figure 3] and [Figure 4].
The histological features of the sections of astemizole and terfenadine treated wounds confirm the pro-healing actions of these two gels.
Wound is a disruption in the continuity of the living tissues. Restoration of the continuity in a damaged area is brought upon by a house keeping mechanism of the body, viz. the repair process. Tissue repair involves regeneration or replacement or, at times both, leading to the healing of a wound. Itching is one of the problems that the patient faces in the healing of a dermal wound. Histamine causes itching. It needs to be contained or it may hamper the healing process or may cause damage to the scar. Doxepin, an antidepressant having antihistaminic activity upon topical use, has been shown to reduce the itching in burn wounds and scars.  However, its influence on healing has not been studied. No treatment either systemic or local (including ointment bases, dressing and suture materials etc.) could be considered inert on the healing process. 
In the light of above, the present study was undertaken to see if topical application of antihistaminic drugs could influence healing. Accordingly, gels of astemizole and terfenadine were prepared and tested for their influence on collagenation, wound contraction and epithelization phases of wound healing, upon topical application to incision and excision wounds. The gels of both astemizole and terfenadine promoted healing in both wound models by influencing collagenation, wound contraction and epithelization phases. While the phase of collagenation gives the required strength to the scars of wounds healed by primary and secondary intentions, wound contraction reduces the gap of the open wound to be filled by extracellular matrix (rich in collagen) and finally covered by epithelium.
Two principal components of collagenation phase are collagen synthesis and maturation. Based on the results of the study, it could be assumed that terfenadine and astemizole might have enhanced the strength of the scar by increasing the collagen levels, which could stitch the wound edges together at the repaired site. However, a number of phases of healing, especially coagulation, inflammation, macrophagia, fibroplasia collagenation, wound contraction and epithelization etc. are intimately interlinked. Therefore, a treatment could influence the healing of a wound by intervening in any one or many phases of healing. Thus, based on the present design, it is very difficult to comment on the exact locations and mechanisms of the pro-healing actions of the topical applications. It is quite possible that the drugs could have had a direct influence on the healing, not withstanding their antihistaminic property. For instance, the base of the gel, while it was inert on the collagenation and epithelization phases, promoted contraction during the first ten days. These kinds of differential effects of bases and drug treatments are known to occur. 
In conclusion, the study reported a new use for drugs such as terfenadine and astemizole. These drugs produce systemic cardiac toxicity following administration in conventional doses. The gels of these drugs could be free from these effects, as the drug concentration reaching systemic circulation from the topical 1% gel applications would be negligible. These gels may, therefore, have the potential to become useful alternatives to systemic antihistaminics, to reduce healing associated itch and to promote healing of wounds in wound care programs.
The authors wish to thank Messers Torrent Pharma, Ahmedabad and Shilpa Organics Pvt Ltd Raichur for the generous gift of terfenadine and astemizole.
|1||Rao CM, George KM, Bairy KL. An appraisal of healing profiles of oral and external (gel) metronidazole on partial thickness burn wound. Indian J Pharmacol 2000;32:282-7.|
|2||Demling RH, De Santhi LR. Topical Doxepin significantly decreases itching and erythema in the chronically pruritic burn scars. Wounds 2003;15:195-200.|
|3||Loganathan V, Manimaran S, Jaswanth A, Suraiman A, Rao MV, Senthil B. The effects of polymers and permeation enhancers on release of flurbiprofen from gel formulations. Indian J Pharm Sci 2001;63:200-4.|
|4||Chiang CM, Flynn GL, Weiner ND, Szpunar GJ. Bioavailability assessment of topical delivery systems: Effect of intersubject variability on relative in-vitro deliveries of minoxidil and hydrocortisone from solution and ointment formulations. Int J Pharma 1989;50:21-6.|
|5||Ehrlich HP, Hunt TK. The effects of cortisone and anabolic steroids on the tensile strength of healing wounds. Ann Surg 1969;170:203-6.|
|6||Lee KH. Studies on the mechanism of action of salicylates II: Retardation of wound healing by aspirin. J Pharm Sci 1968;57:1042-3.|
|7||Morton JJ, Malone MH. Evaluation of vulnerary activity by an open procedure in rats. Arch Int Pharmacodyn Ther 1972;196:117-26.|
|8||Woessner JF Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of the amino acid. Arch Biochem Biophys 1961;93:440-7.|
|9||Jamadar MG, Bairy KL and Kulkarni DR. Vehicle assessment for wound healing profiles. Indian Drugs 1990;27:342-45.|